From: Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
Immunoreactivity
H1.3 + cells
0
0–4%
1
5–24%
2
25–49%
3
50–100%
Intensity
negative
mild
intermediate
intense